Menu

ISTOCK, SVISIO

Genes Tied to Intelligence and Neurotic Behavior Identified

Researchers found several hundred genes expressed in the human brain are tied to cognition or neuroses.

Jun 26, 2018
Sukanya Charuchandra

Several hundred genes linked to intelligence or neuroticism have been reported in two separate studies conducted by the same group and published in Nature today (June 25). 

In one study, the researchers analyzed genetic data and results from neurocognitive tests for more than a quarter of a million people. They identified 939 genes related to intelligence that had not been implicated before. Furthermore, these genes were highly expressed in regions of the brain important for learning and cognition and were connected to genetic pathways involved in nervous system development and the structure of synapses. 

According to Science, people with higher intelligence and longer lifespans were protected from Alzheimer’s disease, ADHD, or schizophrenia, the study found.

In the other study, the group carried out a meta-analysis of earlier research, looking at close to half a million people, and identified 599 genes implicated in neurotic behavior. While some of the genes appeared to be related to depression, others seemed to be coupled with anxiety—both traits of neuroticism. The investigators also found these genes were expressed in particular regions and cell types in the brain.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.